The Medical Expectoration Vest market refers to the global demand for specialized devices designed to aid in the expectoration process, primarily used in respiratory care for patients with chronic obstructive pulmonary disease (COPD), cystic fibrosis, and post-surgical recovery. As part of the broader respiratory therapy equipment industry, this niche segment is gaining traction due to its efficacy in improving patient outcomes by facilitating mucus clearance.
The Medical Expectoration Vest market size is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033, reaching an estimated $120 million by 2033. Key market forecast drivers include rising prevalence of respiratory diseases, advancements in non-invasive pulmonary therapies, and increased adoption of home healthcare solutions. Regulatory tailwinds, such as FDA approvals for innovative vest designs, and a shift toward patient-centric care models are further propelling industry expansion.